Back To Top
State-of-the-art data science and AI power quant models, valuation, sentiment, and volatility analysis. Serious tools built for serious decisions.
AstraZeneca’s Imfinzi Approval Marks Major Advancement in Bladder Cancer Treatment AstraZeneca (NASDAQ: AZN) has made significant strides in cancer care with the U.S. approval of
As earnings season approaches, focusing on individual company fundamentals takes precedence over broad market trends. Portfolio manager George Cipolloni discusses how to identify stable investments
In what has been an eventful week for the cryptocurrency landscape, major developments concerning Bitcoin, Ethereum, Binance, Solana, and Ripple have captured attention. Amidst exhilarating
The People’s Bank of China recently set the USD/CNY reference rate at 7.1782, a shift from Friday’s fix of 7.1752. This adjustment reflects ongoing fluctuations
Demand for Toyota hybrids has skyrocketed, putting immense strain on the supply chain. This surge has led to significant delays, making it difficult for customers
William Lee, the Chief Economist at the Milken Institute, recently shared insights on the minimal effects of tariffs on the economy. He pointed out that
Bitcoin enthusiasts are observing significant accumulation patterns, with seasoned holders stepping back into the market. The Value Days Destroyed metric is at cycle lows, suggesting
The Japanese Yen gains strength as fears surrounding tariffs rise, pushing gold to a new all-time high. Market participants are increasingly drawn to safe-haven assets
